Since the hypoxia-mediated suppression of BDNF has been associated with neuronal loss and spatial memory impairment [60] and GBM patients frequently suffer cognitive deficits, including problems with attention and memory, we therefore conclude that BDNF decrease can contribute to the manifestation of these clinical signs in GBM patients. This evidence concerns the gene BDNF and glioblastoma.